🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.370
+0.090 (7.03%)
At close: Nov 20, 2026, 4:00 PM EST
1.350
-0.020 (-1.46%)
After-hours: Nov 20, 2026, 7:03 PM EST

MaxCyte Revenue

MaxCyte had revenue of $10.15M in the quarter ending September 30, 2026, with 48.66% growth. This brings the company's total for the last twelve months to $34.37M, down -0.13% year-over-year. In the year 2025, MaxCyte had annual revenue of $33.03M, down -14.50%. That makes MaxCyte the 30,564th largest company in the world by revenue and 4,025th in the United States.

Revenue (ttm)
$34.37M
Revenue Growth
-0.13%
P/S Ratio
4.12
Revenue / Employee
$377,736
Employees
91
Market Cap
141.45M

Revenue Chart

Revenue by Geography

  • United States 21.08M 63.8%
  • Outside The United States 11.95M 36.2%
Fiscal year ended Dec 31, 2025 See the full MaxCyte breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202533.03M-5.60M-14.50%
Dec 31, 202438.63M-2.66M-6.44%
Dec 31, 202341.29M-2.97M-6.72%
Dec 31, 202244.26M10.37M30.59%
Dec 31, 202133.89M7.73M29.52%
Dec 31, 202026.17M4.55M21.04%
Dec 31, 201921.62M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Inogen355.06M
Neuronetics159.76M
Quanterix148.15M
RxSight121.83M
Pulmonx88.78M
Electromed75.57M
Apyx Medical59.57M
TriSalus Life Sciences46.39M
Revenue Rankings